ASX-Dividend-Report-Banner

Healthcare


 Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Guess how much $5,000 invested in Sigma shares in December 2023 is w...

February 12, 2025 05:22 PM AEDT | By Team Kalkine Media

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

 CSL (ASX:CSL) Faces Mixed Reactions Following First-Half Report and Analyst Adjustments

CSL (ASX:CSL) Faces Mixed Reactions Following First-Half Report and...

February 12, 2025 02:11 PM AEDT | By Team Kalkine Media

Highlights,CSL (CSL) shares continue to drop after a 5% loss on Tuesday.,Morningstar raised CSL's fair value estimate by 5%, while adjusting future ea...

 Percheron Therapeutics (ASX:PER) Advances Partnership Talks Amid Strategic Growth Plans

Percheron Therapeutics (ASX:PER) Advances Partnership Talks Amid Str...

February 12, 2025 12:46 PM AEDT | By Team Kalkine Media

Highlights,Percheron Therapeutics (,ASX:PER,) expects partnership proposals for its phase IIb trial by the end of February.,The company explores new c...

 Healthcare leaders in the ASX sector juggle multiple roles within this interconnected industry.

Healthcare leaders in the ASX sector juggle multiple roles within th...

February 12, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,ASX healthcare sector leaders frequently engage with multiple companies, providing strategic insight and fostering growth.,Executives like...

 Dr. Boreham’s Crucible: Why is Biotech Giant CSL Creating Such a Stir?

Dr. Boreham’s Crucible: Why is Biotech Giant CSL Creating Such a Sti...

February 12, 2025 11:00 AM AEDT | By Team Kalkine Media

CSL Faces Challenges and Opportunities in Flu Vaccine Market Amidst Diverging Divisional Performance

 Vitura Health Acquires Telehealth Platform for Medical Cannabis

Vitura Health Acquires Telehealth Platform for Medical Cannabis

February 12, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,Vitura Health (ASX:VIT) expands its telehealth portfolio by acquiring Candor Medical for $5.9 million.,CSL (ASX:CSL) experiences mixed reac...

 Island finishes dosing in the Phase 2b segment of its dengue trial, spread by mosquitoes.

Island finishes dosing in the Phase 2b segment of its dengue trial,...

February 12, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Island Pharmaceuticals (ILA) successfully completes Phase 2b trial dosing for ISLA-101, focused on dengue fever treatment.,Results anticip...

 Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

Ansell Limited Mastering Debt Management and Financial Resilience in...

February 11, 2025 07:31 PM AEDT | By Team Kalkine Media

Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

 CSL (ASX:CSL) Shares Fall After Underperforming First-Half Results Amid Vaccine Business Struggles

CSL (ASX:CSL) Shares Fall After Underperforming First-Half Results A...

February 11, 2025 03:41 PM AEDT | By Team Kalkine Media

Highlights,CSL (CSL) misses first-half estimates.,Seqirus vaccine division,impacted,by low influenza,immunisation,rates.,Full-year revenue and NPATA g...

 Botanix Pharmaceuticals (ASX:BOT) Charting the Road to Operational Stability

Botanix Pharmaceuticals (ASX:BOT) Charting the Road to Operational S...

February 11, 2025 03:32 PM AEDT | By Team Kalkine Media

Botanix Pharmaceuticals (ASX:BOT) Charting the Road to Operational Stability

 Ramsay Health Care Shares Surge 4.6% on Tuesday. Here's Why.

Ramsay Health Care Shares Surge 4.6% on Tuesday. Here's Why.

February 11, 2025 11:23 AM AEDT | By Team Kalkine Media

Highlights,Ramsay Health Care shares jumped,4.6% to AU$35.81,, their highest level since December 2023.,The company forecasts,1H25 underlying NPAT of...

 CSL Shares Edge Higher on Half-Year Results, Targets 10-13% NPATA Growth

CSL Shares Edge Higher on Half-Year Results, Targets 10-13% NPATA Gr...

February 11, 2025 11:19 AM AEDT | By Team Kalkine Media

Highlights,CSL shares rose 0.5% to AU$271.68 following the release of its half-year FY25 results.,Revenue grew 5% to US$8.48 billion, while net profit...

 Citi Raises Ansell Price Target Amid Earnings Update and Upgraded Guidance

Citi Raises Ansell Price Target Amid Earnings Update and Upgraded Gu...

February 11, 2025 11:12 AM AEDT | By Team Kalkine Media

Highlights,Citi increased its price target for Ansell to AU$38, up from AU$32.50.,Ansell’s 1H25 adjusted EPS of 55.7 US cents beat consensus estimates...

 CSL’s Plasma Strength, Alcidion’s UK Growth, and Cann Group’s Expansion: Key Market Insights

CSL’s Plasma Strength, Alcidion’s UK Growth, and Cann Group’s Expans...

February 11, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,CSL’s (ASX:CSL) Plasma Business Drives Growth,– Strong demand for immunoglobulin products offsets flu vaccine challenges, boosting net prof...

 CSL (ASX:CSL) Delivers Resilient HY25 Results Amid Market Challenges

CSL (ASX:CSL) Delivers Resilient HY25 Results Amid Market Challenges

February 11, 2025 10:52 AM AEDT | By Team Kalkine Media

Highlights,Revenue Growth:,5% increase in HY25, reaching,$8.48 billion,at,constant currency (CC).,Profit Expansion:,Underlying net profit rose 5% at C...

 CSL shares increased by 6% due to strong demand for its CSL Behring division.

CSL shares increased by 6% due to strong demand for its CSL Behring...

February 11, 2025 10:30 AM AEDT | By Team Kalkine Media

CSL shares increased by 6% due to strong demand for its CSL Behring division.

 Stakeholder Dynamics at Ramsay Health Care (ASX:RHC)

Stakeholder Dynamics at Ramsay Health Care (ASX:RHC)

February 11, 2025 09:31 AM AEDT | By Team Kalkine Media

Highlights,Institutions hold a 41% stake in Ramsay Health Care (RHC).,The top seven shareholders control over half of the company.,General public main...

 Mayne Pharma (ASX:MYX) Shares Surge on Strong Forecast for 275% Revenue Growth

Mayne Pharma (ASX:MYX) Shares Surge on Strong Forecast for 275% Reve...

February 10, 2025 01:41 PM AEDT | By Team Kalkine Media

Highlights,Mayne Pharma (,ASX:MYX,) shares jump 20.5% on positive forecast,Forecasted earnings before interest, tax, depreciation, and amortization (E...

 Ansell Shares Surge to Three-Year High on Strong Earnings Outlook

Ansell Shares Surge to Three-Year High on Strong Earnings Outlook

February 10, 2025 01:29 PM AEDT | By Team Kalkine Media

Highlights,Ansell shares hit a three-year high, jumping 6.7% to AU$37.26.,Company raises FY25 earnings guidance, beating analyst expectations.,First-h...

 Mayne Pharma (ASX: MYX) Forecasts Strong 1H25 Revenue Growth with Robust EBITDA Surge

Mayne Pharma (ASX: MYX) Forecasts Strong 1H25 Revenue Growth with Ro...

February 10, 2025 12:59 PM AEDT | By Team Kalkine Media

Highlights,Mayne Pharma expects up to $215 million in revenue for 1H25.,Projected EBITDA increase of,nearly 300%,year-on-year.,Focus on Women’s Health...

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.